These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28437537)

  • 1. Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
    Fedewa SA; Ward EM; Brawley O; Jemal A
    JAMA Intern Med; 2017 Jul; 177(7):1040-1042. PubMed ID: 28437537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US guideline may have led to drop in PSA testing among primary care physicians, studies find.
    McCarthy M
    BMJ; 2015 May; 350():h2906. PubMed ID: 26021822
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
    Østerø Í Jákupsstovu J; Brodersen J
    BMJ; 2018 May; 361():k1202. PubMed ID: 29724877
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer screening in New Zealand.
    Gray B
    N Z Med J; 2013 Sep; 126(1383):94. PubMed ID: 24157998
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.
    Donnelly L; Sternberg KM; Ashikaga T; Plante MK; Perrapato SD
    J Community Health; 2018 Feb; 43(1):33-37. PubMed ID: 28620736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.
    Printz C
    Cancer; 2018 Jan; 124(1):11-12. PubMed ID: 29251768
    [No Abstract]   [Full Text] [Related]  

  • 11. Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines.
    Rooney MK; Morgans AK; Chen RC; Golden DW; Meeks JJ; Auffenberg G; Kundu SD; Schaeffer EM; Hussain MH; Kalapurakal JA; Sachdev S
    Urology; 2020 Jan; 135():1-3. PubMed ID: 31669135
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
    Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
    JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate Specific Antigen (PSA), yet how much damage?].
    Braillon A; Hill C; Dubois G
    Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physicians' use of an informed decision-making process for prostate cancer screening.
    Volk RJ; Linder SK; Kallen MA; Galliher JM; Spano MS; Mullen PD; Spann SJ
    Ann Fam Med; 2013; 11(1):67-74. PubMed ID: 23319508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen screening: An update of physician beliefs and practices.
    Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
    Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.
    Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Jul; 46(1):2-13. PubMed ID: 7541583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.